Brookstone Capital Management Edwards Lifesciences Corp Transaction History

Brookstone Capital Management

$5.32 Billion
Q2 2024

A detailed history of Brookstone Capital Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Brookstone Capital Management holds 7,282 shares of EW stock, worth $476,825. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,282

Previous 12,275 40.68%

Holding current value

$476,825

Previous $1.17 Million 42.66%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$84.3 - $94.31 $420,909 - $470,889	-4,993 Reduced 40.68%	7,282 $672,000
Q1 2024 Apr 15, 2024	BUY	$72.54 - $95.56 $27,782 - $36,599	383 Added 3.22%	12,275 $1.17 Million
Q4 2023 Jan 11, 2024	BUY	$61.71 - $77.76 $55,045 - $69,361	892 Added 8.11%	11,892 $906,000
Q3 2023 Oct 20, 2023	SELL	$69.28 - $93.38 $259,661 - $349,988	-3,748 Reduced 25.41%	11,000 $762,000
Q2 2023 Jul 11, 2023	BUY	$81.41 - $94.33 $542,841 - $628,992	6,668 Added 82.52%	14,748 $1.39 Million
Q1 2023 Apr 18, 2023	BUY	$74.26 - $84.51 $124,459 - $141,638	1,676 Added 26.17%	8,080 $668,000
Q4 2022 Jan 09, 2023	BUY	$68.3 - $87.44 $18,372 - $23,521	269 Added 4.38%	6,404 $0
Q3 2022 Oct 13, 2022	BUY	$82.37 - $107.29 $11,614 - $15,127	141 Added 2.35%	6,135 $507,000
Q2 2022 Jul 11, 2022	BUY	$86.5 - $128.27 $19,289 - $28,604	223 Added 3.86%	5,994 $590,000
Q1 2022 Apr 12, 2022	BUY	$101.96 - $128.34 $588,411 - $740,650	5,771 New	5,771 $701,000
Q2 2021 Jul 14, 2021	SELL	$83.84 - $104.76 $564,159 - $704,930	-6,729 Closed	0 $0
Q1 2021 Apr 16, 2021	BUY	$78.68 - $90.67 $12,903 - $14,869	164 Added 2.5%	6,729 $563,000
Q4 2020 Jan 13, 2021	BUY	$71.69 - $91.23 $8,244 - $10,491	115 Added 1.78%	6,565 $599,000
Q3 2020 Oct 13, 2020	SELL	$67.19 - $87.44 $42,195 - $54,912	-628 Reduced 8.87%	6,450 $515,000
Q2 2020 Jul 21, 2020	BUY	$57.54 - $76.95 $258,239 - $345,351	4,488 Added 173.28%	7,078 $489,000
Q1 2020 Apr 14, 2020	SELL	$52.41 - $81.0 $4,559 - $7,047	-87 Reduced 3.25%	2,590 $489,000
Q4 2019 Jan 29, 2020	SELL	$71.7 - $82.09 $7,743 - $8,865	-108 Reduced 3.88%	2,677 $625,000
Q3 2019 Oct 18, 2019	SELL	$61.55 - $75.43 $21,234 - $26,023	-345 Reduced 11.02%	2,785 $612,000
Q2 2019 Jul 25, 2019	BUY	$55.74 - $64.41 $18,840 - $21,770	338 Added 12.11%	3,130 $578,000
Q1 2019 Apr 18, 2019	BUY	$47.89 - $64.05 $14,989 - $20,047	313 Added 12.63%	2,792 $534,000
Q4 2018 Feb 06, 2019	SELL	$46.41 - $56.94 $5,847 - $7,174	-126 Reduced 4.84%	2,479 $380,000
Q3 2018 Nov 05, 2018	BUY	$45.7 - $58.03 $24,723 - $31,394	541 Added 26.21%	2,605 $454,000
Q2 2018 Aug 06, 2018	SELL	$42.45 - $51.3 $22,158 - $26,778	-522 Reduced 20.19%	2,064 $300,000
Q1 2018 Apr 23, 2018	BUY	$37.19 - $47.45 $96,173 - $122,705	2,586 New	2,586 $361,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Account

Brookstone Capital Management Edwards Lifesciences Corp Transaction History